Long Haul for Breast Cancer Survivors: Disease Can Return After 20 Years

New research shows that long-term endocrine therapy can reduce the risk of breast cancer recurrence in the long term. But side effects keep some women from taking it.

Copyright Disclaimer:This article has been RSS syndicated and was originally published here.